- Home
- RGS vs KLRS Comparison
RGS vs KLRS Comparison
Compare RGS & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- KLRS
- Stock Information
- Founded
- RGS 1922
- KLRS 2019
- Country
- RGS United States
- KLRS United States
- Employees
- RGS N/A
- KLRS N/A
- Industry
- RGS Other Consumer Services
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RGS Consumer Discretionary
- KLRS Health Care
- Exchange
- RGS Nasdaq
- KLRS Nasdaq
- Market Cap
- RGS 47.4M
- KLRS 46.0M
- IPO Year
- RGS 1991
- KLRS N/A
- Fundamental
- Price
- RGS $20.96
- KLRS $3.68
- Analyst Decision
- RGS
- KLRS Buy
- Analyst Count
- RGS 0
- KLRS 1
- Target Price
- RGS N/A
- KLRS N/A
- AVG Volume (30 Days)
- RGS 8.2K
- KLRS 63.7K
- Earning Date
- RGS 09-03-2025
- KLRS 08-13-2025
- Dividend Yield
- RGS N/A
- KLRS N/A
- EPS Growth
- RGS N/A
- KLRS N/A
- EPS
- RGS 41.20
- KLRS N/A
- Revenue
- RGS $199,112,000.00
- KLRS N/A
- Revenue This Year
- RGS N/A
- KLRS N/A
- Revenue Next Year
- RGS N/A
- KLRS N/A
- P/E Ratio
- RGS $0.60
- KLRS N/A
- Revenue Growth
- RGS N/A
- KLRS N/A
- 52 Week Low
- RGS $15.00
- KLRS $2.14
- 52 Week High
- RGS $29.28
- KLRS $24.15
- Technical
- Relative Strength Index (RSI)
- RGS 70.20
- KLRS 70.31
- Support Level
- RGS $18.56
- KLRS $2.37
- Resistance Level
- RGS $19.84
- KLRS $2.58
- Average True Range (ATR)
- RGS 0.73
- KLRS 0.22
- MACD
- RGS 0.51
- KLRS 0.08
- Stochastic Oscillator
- RGS 100.00
- KLRS 96.23
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.